ArticleNature communications2025
Selective transformation of propargylic ester towards tunable polymerization pathways.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Divergent synthesis of numerous complex molecules has emerged as a promising strategy as it allows the access to structurally distinct products from identical starting materials. However, selective transformation of the same monomer into diverse polymers by modulating the polymerization conditions remains a synthetic challenge. In this work, we report the design of propargylic ester, which can be selectively transformed into polyimidate, polyimine, or polyamidine through distinct polymerization pathways. By modulating polymerization conditions, either ester migrating or ester leaving can be selectively manipulated with the formation of different nitrogen-containing intermediates including imine, ketenimine, and alkylidene ketenimine. Three types of polymers could be exclusively obtained using one set of monomer combination containing propargylic ester and sulfonyl azide. In this work, the tunable ester leaving or migrating ability for propargylic ester allows it as a variable synthon monomer, which can facilitate varied transformations towards structure-diverse polymers.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.